InvestorsHub Logo
icon url

lasers

02/16/12 8:44 AM

#40686 RE: rocky301 #40685

Thanks Rocky.

Finally an explanation of why there has not yet been additional AMD patients selected.
icon url

diannedawn

02/16/12 9:36 AM

#40691 RE: rocky301 #40685

Thanks! Rocky! I'm glad he explained that.
It must have been very disappointing for those people
(as he mentioned)
to be excluded from the trial, after thinking they had made it in.
:(
icon url

KeazysKeepers

02/16/12 1:35 PM

#40706 RE: rocky301 #40685

definitely makes a lot of sense. I didn't think about that. I'm happy to hear that the delay has nothing to do with the findings. Let's hope patients 2 and 3 are treated this month or soon after and show signs of engraftment and/or sight improvement and/or no complications.
icon url

farviewhill

02/16/12 1:36 PM

#40707 RE: rocky301 #40685

Thanks, ROCKY. I understand that one of the patient screening impediments, if you will, is the eye sight parameters required/initial study approved, by the FDA.

Are you observing anywhere a change in those parameters, or does that, if meaningful for the clinicals, mean going back to step one and study re-design approval with the FDA?
Thanks.